The effect of Ksheerabala oil in sleep disturbances

An open label single arm clinical study to evaluate the effectiveness of shirobasti in nidranasha.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023436

Enrollment

Registered

2020-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G470- Insomnia

Interventions

Intervention1: Shirobasti: Shirobasti will be done with ksheerabala taila for 7 consecutive days. Intervention2: Shirobasti: Shirobasti with Ksheerabala taila for 7 consecutive days. Control Intervent

Eligibility

Inclusion criteria

Inclusion criteria: Having clinical symptoms of nidranasha. Fit for shirobasti. Willing to [articipate in the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: History of psychiatric illness. Alcoholics. Diagnosed cases of systemic disorders like chronic heart disease, chronic renal failure and chronic liver disease.

Design outcomes

Primary

Measure	Time frame
Symptoms of insomnia will be assessed and the improvement will be recorded as per Insomnia Severity Index scale.Timepoint: Symptoms of insomnia will be assessed on first(BT), seventh(AT) and fifteenth day(follow up) and the improvement will be recorded as per Insomnia Severity Index scale.	—

Secondary

Measure	Time frame
Samyak shirobasti lakshanas will be assessedTimepoint: Day 1,2,3,4,5,6,7	—

Countries

India

Contacts

Public ContactDr Muralidhar P Pujar

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

drmuralidharpujar@sdmcahhassan.org9448033718

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026